Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Healthtrust
Moodys
Novartis
Teva
Daiichi Sankyo
McKinsey
Accenture
McKesson

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,998,467

« Back to Dashboard

Which drugs does patent 7,998,467 protect, and when does it expire?

Patent 7,998,467 protects DIFFERIN and is included in one NDA.

This patent has seventeen patent family members in twelve countries.
Summary for Patent: 7,998,467
Title:Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Abstract: Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid compound and at least one polyurethane polymer or derivative thereof, the at least one naphthoic acid compound being dispersed therein.
Inventor(s): Mallard; Claire (Mougins, FR), Ferrara; Eve (Valbonne, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:12/076,169
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form; Process;

Drugs Protected by US Patent 7,998,467

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp DIFFERIN adapalene LOTION;TOPICAL 022502-001 Mar 17, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF ACNE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,998,467

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France05 09493Sep 16, 2005

Non-Orange Book US Patents Family Members for Patent 7,998,467

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,435,502 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers ➤ Sign Up
8,709,392 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,998,467

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2421216 ➤ Sign Up
Russian Federation 2008114840 ➤ Sign Up
Mexico 2008003422 ➤ Sign Up
South Korea 101358490 ➤ Sign Up
South Korea 20080050579 ➤ Sign Up
Japan 2012184258 ➤ Sign Up
Japan 5074401 ➤ Sign Up
Japan 2009508843 ➤ Sign Up
France 2890861 ➤ Sign Up
European Patent Office 1933827 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
Johnson and Johnson
UBS
McKesson
QuintilesIMS
Chubb
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot